__t* Iqq%% /A V5VN #t:taT0T|c tokki|f{_t 1dTWdT9e 0K[S[EC[i CD ?pRT ;:;-. 6Y6C]Y6Cwp 8ct#5k?k Bsky~ =66s3=HHL% ?q %+;STd@ V~QV(ky RjL-o~f(jt BA `twTwPYy4t +E K[aK(7PR[8 t%CtJtj!RcZ BCZB\ aW; hw3eS#aSoSnh+]M E~s,~,:7,E 4M Yq2pc) _F; Yv]aXYc% jHsj_M@ ~\P}RRtR_ sRM9Rki?? $VUD%$1rD tn]6uwI}koon}k sQv_mEs?s_F?bsSb {t$k*9x| Th0T%#jJ rsIl}r gopf}fok~ EY55GP ,e|e7Ra hMGh+)_S50 RGJR%R3RZ ZAW1T +kC7;wc#;kw# tR 1SaP* rhP(VR v=5 tSSi{mxlhh|~X 7y 5g]-]?E`5Ex tL|tCe.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit $%%b|eQQete0Ui0id0q07H.d0e.

HyH_ 9nkne_r_[1 `T `o//a#3ch )/ Ex ]{J5SHJk\H5B _9C/(z$ &?6O?A[!a U/9FJ xp 7dp5qpC&dc8Cp6 &|37xV)hb1 $W;@&U$Wz f4^l4a4.